Product
EB-101
Aliases
EB-101 Surgical application of RDEB wounds
3 clinical trials
2 indications
Indication
Epidermolysis BullosaClinical trial
A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)Status: , Estimated PCD: 2036-02-01
Clinical trial
A Phase 3b Study for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) in New and Previously EB-101 Treated PatientsStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
VIITAL: A Phase 3 Study of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)Status: Completed, Estimated PCD: 2022-10-18